Senthamil Selvan

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address1015 Walnut St.
Philadelphia PA 19107
Phone215-955-1195
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hu-Lieskovan S, Bhaumik S, Dhodapkar K, Grivel JJB, Gupta S, Hanks BA, Janetzki S, Kleen TO, Koguchi Y, Lund AW, Maccalli C, Mahnke YD, Novosiadly RD, Selvan SR, Sims T, Zhao Y, Maecker HT. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery. J Immunother Cancer. 2020 Dec; 8(2). PMID: 33268350.
      Citations:    
    2. Krishnan VV, Selvan SR, Parameswaran N, Venkateswaran N, Luciw PA, Venkateswaran KS. Proteomic profiles by multiplex microsphere suspension array. J Immunol Methods. 2018 Oct; 461:1-14. PMID: 30003895.
      Citations:    
    3. Tabarkiewicz J, Selvan SR, Cools N. Autoimmunity in Reproductive Health and Pregnancy. J Immunol Res. 2018; 2018:9501865. PMID: 29651446.
      Citations:    
    4. Ravindranath MH, Cai J, Ferrone S, Claas FHJ, Selvan SR. The Humoral Theory of Transplantation. J Immunol Res. 2017; 2017:5935123. PMID: 28929124.
      Citations:    
    5. Dobbin KK, Cesano A, Alvarez J, Hawtin R, Janetzki S, Kirsch I, Masucci GV, Robbins PB, Selvan SR, Streicher HZ, Zhang J, Butterfield LH, Thurin M. Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations. J Immunother Cancer. 2016; 4:77. PMID: 27891226.
      Citations:    
    6. Masucci GV, Cesano A, Hawtin R, Janetzki S, Zhang J, Kirsch I, Dobbin KK, Alvarez J, Robbins PB, Selvan SR, Streicher HZ, Butterfield LH, Thurin M. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation. J Immunother Cancer. 2016; 4:76. PMID: 27895917.
      Citations:    
    7. Selvan SR, Dowling JP, Kelly WK, Lin J. Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies. Curr Cancer Drug Targets. 2016; 16(9):755-764. PMID: 26517538.
      Citations:    
    8. Selvan SR, Dowling JP. "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy. Biomed Res Int. 2015; 2015:869547. PMID: 26161419.
      Citations:    
    9. Kavuri V, Raghuram N, Malamud A, Selvan SR. Irritable Bowel Syndrome: Yoga as Remedial Therapy. Evid Based Complement Alternat Med. 2015; 2015:398156. PMID: 26064164.
      Citations:    
    10. Cao P, Selvan SR, Küpeli Akkol E, Wang N, Yang H, Cheng X. Complementary and alternative medicine in cancer prevention and therapy. Evid Based Complement Alternat Med. 2015; 2015:639372. PMID: 25922613.
      Citations:    
    11. Erkes DA, Selvan SR. Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity. J Immunol Res. 2014; 2014:175265. PMID: 24949488.
      Citations:    
    12. Kumari J, Selvan SR, Becart S, Chattopadhyay S, Dalmo RA. Cell-mediated immunity and vaccines. J Immunol Res. 2014; 2014:632632. PMID: 24741611.
      Citations:    
    13. Yoshida M, Selvan S, McCue PA, Deangelis T, Baserga R, Fujii A, Rui H, Mastrangelo MJ, Sato T. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth. Pigment Cell Melanoma Res. 2014 Mar; 27(2):297-308. PMID: 24354797.
      Citations:    
    14. Manjili MH, Egilmez N, Knutson KL, Selvan SR, Ostberg JR. Tumor Escape and Progression under Immune Pressure. Clin Dev Immunol. 2012; 2012:641079. PMID: 23316254.
      Citations:    
    15. Ben-Arye E, Cassileth B, Heusser P, Afifi F, Saad B, Selvan SR. Complementary and integrative oncology in the cross-cultural region of the middle East and South Asia. Evid Based Complement Alternat Med. 2012; 2012:940961. PMID: 22577467.
      Citations:    
    16. Ravindranath MH, Selvan SR, Terasaki PI. Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFN?-treated autologous melanoma cell vaccine recipients. J Immunotoxicol. 2012 Jul-Sep; 9(3):282-91. PMID: 22283601.
      Citations:    
    17. Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res. 2011 Dec; 51(2-3):170-82. PMID: 22139852.
      Citations:    
    18. Dillman RO, Fogel GB, Cornforth AN, Selvan SR, Schiltz PM, DePriest C. Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines. Cancer Biother Radiopharm. 2011 Aug; 26(4):407-15. PMID: 21812653.
      Citations:    
    19. Selvan SR, Sheehy PF, Heinemann FS, Anbuganapathi S. Bone marrow failure due to T-cell large granular lymphocytic leukemia in a patient with essential thrombocythemia. Leuk Res. 2011 Feb; 35(2):278-82. PMID: 20934219.
      Citations:    
    20. Dillman RO, Nanci AA, Williams ST, Kim RB, Hafer RL, Coleman CL, Wang PC, Duma CM, Chen PV, Selvan SR, Cornforth AN, DePriest C. Durable complete response of refractory, progressing metastatic melanoma after treatment with a patient-specific vaccine. Cancer Biother Radiopharm. 2010 Oct; 25(5):553-7. PMID: 20849310.
      Citations:    
    21. Selvan SR, Carbonell DJ, Fowler AW, Beatty AR, Ravindranath MH, Dillman RO. Establishment of stable cell lines for personalized melanoma cell vaccine. Melanoma Res. 2010 Aug; 20(4):280-92. PMID: 20375743.
      Citations:    
    22. Dillman RO, Selvan SR, Schiltz PM, McClay EF, Barth NM, DePriest C, de Leon C, Mayorga C, Cornforth AN, Allen K. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. Cancer Biother Radiopharm. 2009 Jun; 24(3):311-9. PMID: 19538053.
      Citations:    
    23. Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Håkansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL, Stroncek DF, Streicher H, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM. A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J Transl Med. 2008; 6:81. PMID: 19105846.
      Citations:    
    24. Selvan SR, Dillman RO, Fowler AW, Carbonell DJ, Ravindranath MH. Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker. Int J Cancer. 2008 Mar 15; 122(6):1374-83. PMID: 17960619.
      Citations:    
    25. Kumar M, Samarth R, Kumar M, Selvan SR, Saharan B, Kumar A. Protective effect of Adhatoda vascia Nees against radiation-induced damage at cellular, biochemical and chromosomal levels in Swiss albino mice. Evid Based Complement Alternat Med. 2007 Sep; 4(3):343-50. PMID: 17965765.
      Citations:    
    26. Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Santin AD, Bellone S, Saravanan TS, Morton DL. Immunogenic gangliosides in human ovarian carcinoma. Biochem Biophys Res Commun. 2007 Feb 9; 353(2):251-8. PMID: 17188646.
      Citations:    
    27. Dillman RO, Selvan SR, Schiltz PM. Patient-specific dendritic-cell vaccines for metastatic melanoma. N Engl J Med. 2006 Sep 14; 355(11):1179-81. PMID: 16971731.
      Citations:    
    28. Ravindranath MH, Saravanan TS, Monteclaro CC, Presser N, Ye X, Selvan SR, Brosman S. Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines. Evid Based Complement Alternat Med. 2006 Jun; 3(2):237-47. PMID: 16786054.
      Citations:    
    29. Dillman RO, Beutel L, Nayak S, Depriest C, Selvan S, Schiltz P. Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes? Cancer Biother Radiopharm. 2005 Aug; 20(4):373-8. PMID: 16114985.
      Citations:    
    30. Selvan SR, Cornforth AN, Rao NP, Reid YA, Schiltz PM, Liao RP, Price DT, Heinemann FS, Dillman RO. Establishment and characterization of a human primary prostate carcinoma cell line, HH870. Prostate. 2005 Apr 1; 63(1):91-103. PMID: 15468172.
      Citations:    
    31. Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5; 324(1):154-65. PMID: 15464996.
      Citations:    
    32. Dillman R, Barth N, Selvan S, Beutel L, de Leon C, DePriest C, Peterson C, Nayak S. Phase I/II trial of autologous tumor cell line-derived vaccines for recurrent or metastatic sarcomas. Cancer Biother Radiopharm. 2004 Oct; 19(5):581-8. PMID: 15650450.
      Citations:    
    33. Dillman R, Selvan S, Schiltz P, Peterson C, Allen K, Depriest C, McClay E, Barth N, Sheehy P, de Leon C, Beutel L. Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis. Cancer Biother Radiopharm. 2004 Oct; 19(5):658-65. PMID: 15650459.
      Citations:    
    Selvan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (93)
    Explore
    _
    Co-Authors (6)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _